Connection

Raymond DuBois to Prostaglandin-Endoperoxide Synthases

Back to Details
This is a "connection" page, showing publications Raymond DuBois has written about Prostaglandin-Endoperoxide Synthases.
Raymond DuBois
Connection Strength
4.390
Prostaglandin-Endoperoxide Synthases
  1. The Role of Prostaglandin E(2) in Tumor-Associated Immunosuppression. Trends Mol Med. 2016 Jan; 22(1):1-3.
    View in: PubMed
    Score: 0.511
  2. Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Dev Biol. 2006 Jan 15; 289(2):263-72.
    View in: PubMed
    Score: 0.255
  3. Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2. Gastroenterology. 2005 Aug; 129(2):577-90.
    View in: PubMed
    Score: 0.249
  4. Cyclooxygenase-1 signaling is required for vascular tube formation during development. Dev Biol. 2005 Jun 01; 282(1):274-83.
    View in: PubMed
    Score: 0.246
  5. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol. 2005 Apr 20; 23(12):2840-55.
    View in: PubMed
    Score: 0.244
  6. Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Res. 2005 Mar 01; 65(5):1822-9.
    View in: PubMed
    Score: 0.242
  7. Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor. Gastroenterology. 2004 Nov; 127(5):1391-400.
    View in: PubMed
    Score: 0.237
  8. Cyclooxygenase as a target in lung cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 2):4266s-4269s.
    View in: PubMed
    Score: 0.230
  9. Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture. Chest. 2004 May; 125(5 Suppl):134S-40S.
    View in: PubMed
    Score: 0.228
  10. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J. 2004 May-Jun; 10(3):145-52.
    View in: PubMed
    Score: 0.228
  11. Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):415-6.
    View in: PubMed
    Score: 0.223
  12. Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging. Mol Imaging Biol. 2003 Sep-Oct; 5(5):286-303.
    View in: PubMed
    Score: 0.218
  13. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 2003 Mar 01; 63(5):906-11.
    View in: PubMed
    Score: 0.211
  14. Measurement of eicosanoids in cancer tissues. Methods Enzymol. 2007; 433:27-50.
    View in: PubMed
    Score: 0.069
  15. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2. Oncology. 2005; 69 Suppl 1:28-32.
    View in: PubMed
    Score: 0.063
  16. Cyclooxygenase-2-mediated DNA damage. J Biol Chem. 2005 Aug 05; 280(31):28337-46.
    View in: PubMed
    Score: 0.062
  17. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 2005 May 01; 65(9):3735-44.
    View in: PubMed
    Score: 0.061
  18. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol. 2005 Jan 10; 23(2):254-66.
    View in: PubMed
    Score: 0.060
  19. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem. 2005 Feb 04; 280(5):3217-23.
    View in: PubMed
    Score: 0.059
  20. COX-2 inhibition and colorectal cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):12-21.
    View in: PubMed
    Score: 0.057
  21. Cyclooxygenase-2: a potential target in breast cancer. Semin Oncol. 2004 Feb; 31(1 Suppl 3):64-73.
    View in: PubMed
    Score: 0.056
  22. Will an aspirin a day keep the endoscope away? Gastroenterology. 2003 Aug; 125(2):612-4.
    View in: PubMed
    Score: 0.054
  23. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem. 2003 Sep 12; 278(37):35451-7.
    View in: PubMed
    Score: 0.054
  24. Evaluation of the whole prostaglandin biosynthetic pathway in lung cancer. Clin Cancer Res. 2003 May; 9(5):1577-8.
    View in: PubMed
    Score: 0.053
  25. The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer. Expert Opin Emerg Drugs. 2003 May; 8(1):1-7.
    View in: PubMed
    Score: 0.053
  26. Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res. 2003; 37:124-37.
    View in: PubMed
    Score: 0.052
  27. New agents for cancer prevention. J Natl Cancer Inst. 2002 Dec 04; 94(23):1732-3.
    View in: PubMed
    Score: 0.052
  28. New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity. Best Pract Res Clin Gastroenterol. 2002 Dec; 16(6):945-56.
    View in: PubMed
    Score: 0.052
  29. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res. 2002 Jun 01; 62(11):3282-8.
    View in: PubMed
    Score: 0.050
  30. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus. J Natl Cancer Inst. 2002 Mar 20; 94(6):406-7.
    View in: PubMed
    Score: 0.049
  31. COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol. 2002; 42:55-80.
    View in: PubMed
    Score: 0.049
  32. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002; 53:35-57.
    View in: PubMed
    Score: 0.049
  33. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions. Surgery. 2003 May; 133(5):568-79.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.